Patients Are Suing Feds Over Drug Shortages
Source: Pharmalot More than two dozen people who suffered medication shortages have filed a lawsuit against the US Department of Health and Human Services, the FDA and the National Institutes of Health, arguing their rights were violated because the federal government failed to take adequate enforcement actions against such drugmakers and allow for alternative means […]
Read More »Category : News
J&J Scandals Bring Down CEO
Source: Pharmalot After more than two years of controversy over manufacturing gaffes and product recalls, Bill Weldon is retiring as Johnson & Johnson ceo in April, ending a 10-year reign at the top of one of the most venerable, but now tarnished names, in corporate America. The 63-year-old Weldon will be replaced by Alex Gorsky, […]
Read More »Category : News
Teva Doles Out $250 Mil to End Lawsuits on Propofol
Source: Pharmalot Yet another drugmaker has agreed to settle a large backload of product liability lawsuits. In the latest instance, Teva Pharmaceutical will pay more than $250 million to settle more than 80 lawsuits alleging the drugmaker intentionally sold its Propofol anesthetic in vials that were large enough to be reused by doctors, but led […]
Read More »Category : News
Fake Avastin was shipped by accident, Danish distributor says
Danish drug distributor CareMed said it was an unwitting link in the journey of fake cancer medicine Avastin from Switzerland to Britain, in the latest twist in a saga that began when the counterfeit drugs surfaced in the United States last year. Don’t miss these Health stories Chuck Eaton via flashesofhope.or Hospitals scramble for scarce […]
Read More »Category : News
Mylan Agrees to Settle Defamation Suit Against Paper
Source: Pharmalot Nearly three years after The Pittsburgh Post-Gazette ran a controversial story that indicated Mylan Laboratories employees routinely violated quality-control procedures at a facility in Morgantown, West Virginia, the drugmaker and the newspaper have settled the litigation, according to a joint statement issued by Mylan and the newspaper. “The Post-Gazette did not find and […]
Read More »Category : News
Feds Bring Subpoena on Bristol Myers Regarding Marketing for Abilify
Source: Pharmalot In September 2007, Bristol-Myers Squibb agreed to settle charges of giving kickbacks to docs and overcharging the government. Among the infractions alleged by the federal and state governments was off-label promotion of its Abilify antipsychotic, and the drugmaker subsequently paid $515 million and signed a five-year corporate integrity agreement. Could there have been […]
Read More »Category : News
Novartis Stops Parts of Production at Yet Another Manufacturing Plant
Source: Pharmalot For the second time in less than three months, Novartis has been forced to halt production of medicines at one of its plants after recent FDA inspections found various manufacturing problems. This time, its Sandoz unit has suspended or discontinued production of some medicines at a facility in Boucherville, Quebec. In December, all […]
Read More »Category : News
Fake Avastin Causing Major Uproar in National Media
Source: Pharmalot For the past couple of days, the controversy over counterfeit Avastin – the cancer med sold by Roche and its Genentech unit – has made national headlines and renewed fears about phony meds making their way through the supply chain. The timing could not be worse, coming just as the crisis over assorted […]
Read More »Category : News
Trade Group CEO in Pakistan Resigns in Disgust
Source: Pharmalot Over the past month, the Pakistani pharmaceutical industry has been roiled by a scandal in which at least 130 people died after taking a contaminated heart medication. Yesterday, however, the acting chair of the Pakistan Pharmaceutical Manufacturers Association added some drama to the episode by reading a statement at a press conference – […]
Read More »Category : News
J&J the Victor in Its First Risperdal Product Liability Suit
Source: Pharmalot In the first lawsuit to go to trial over personal injuries attributed to the Risperdal antipsychotic, a New Jersey jury decided in a 5-to-1 vote that the Johnson & Johnson drug was not a substantial factor in causing a 56-year-old man to develop diabetes. However, the jury also voted 5-to-1 that the health […]
Read More »Category : News
